|
LUZP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.49219999995487E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.430810E-01 |
| Normal-vs-Stage2 |
5.811300E-04 |
| Normal-vs-Stage3 |
5.06650055243085E-10 |
| Normal-vs-Stage4 |
2.82059997580575E-09 |
| Stage1-vs-Stage2 |
2.626500E-02 |
| Stage1-vs-Stage3 |
2.01179999992362E-07 |
| Stage1-vs-Stage4 |
5.04339999984893E-07 |
| Stage2-vs-Stage3 |
2.320600E-01 |
| Stage2-vs-Stage4 |
1.205550E-01 |
| Stage3-vs-Stage4 |
5.150800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.77755999999363E-05 |
| Normal-vs-AfricanAmerican |
2.715400E-03 |
| Normal-vs-Asian |
6.115600E-01 |
| Caucasian-vs-AfricanAmerican |
3.411800E-01 |
| Caucasian-vs-Asian |
6.186400E-01 |
| AfricanAmerican-vs-Asian |
4.657200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.60809999982803E-07 |
| Normal-vs-Female |
2.128200E-02 |
| Male-vs-Female |
8.458700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.047800E-02 |
| Normal-vs-Age(41-60Yrs) |
4.203800E-03 |
| Normal-vs-Age(61-80Yrs) |
8.47240000045879E-07 |
| Normal-vs-Age(81-100Yrs) |
5.56320000000277E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.729000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.679400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.053400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.974400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.818300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.215000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.086800E-01 |
| Normal-vs-Grade 2 |
1.512230E-01 |
| Normal-vs-Grade 3 |
1.8257000355959E-09 |
| Normal-vs-Grade 4 |
4.6659998087506E-10 |
| Grade 1-vs-Grade 2 |
6.867800E-02 |
| Grade 1-vs-Grade 3 |
2.368200E-02 |
| Grade 1-vs-Grade 4 |
8.344600E-03 |
| Grade 2-vs-Grade 3 |
2.10720000004549E-06 |
| Grade 2-vs-Grade 4 |
1.29649999958126E-07 |
| Grade 3-vs-Grade 4 |
5.144300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.711200E-01 |
| Normal-vs-ccB subtype |
1.62360000000028E-07 |
| ccA subtype-vs-ccB subtype |
3.87420000003136E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.03579999999981E-05 |
| Normal-vs-N1 |
1.015960E-02 |
| N0-vs-N1 |
2.163400E-01 |
|
|
